Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-22-018976
Filing Date
2022-03-15
Accepted
2022-03-15 19:12:11
Documents
1
Period of Report
2022-03-11

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4181
  Complete submission text file 0001209191-22-018976.txt   5682
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Issuer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 WEST MONROE ST., SUITE 1575 CHICAGO IL 60606
Business Address
Matthews Judith M. (Reporting) CIK: 0001734033 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38503 | Film No.: 22742783